Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region

European Journal of Pharmacology

Volumn 349, Issue 1, 1998, Pages 83-87

  Pilc, Andrzej ^a   Brański, Piotr ^a   Pałucha, Agnieszka ^a   Tokarski, Krzysztof ^a   Bijak, Maria ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

((R,S) 3,5 dihydroxy phenylglycine); (R,S) 3,5 DHPG; 1S,3R ACPD ((1S,3R) 1 carboxycyclopentane 3 acetic acid); Antidepressant; CA1 region; Electroconvulsive shock; Hippocampus; Imipramine; Inositol phosphate; Metabotropic glutamate receptor

Indexed keywords

1 CARBOXYCYCLOPENTANE 3 ACETIC ACID; 3,5 DIHYDROXYPHENYLGLYCINE; GLUTAMATE RECEPTOR ANTAGONIST; IMIPRAMINE; INOSITOL PHOSPHATE; METABOTROPIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN SLICE; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; SPIKE;

ACTION POTENTIALS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYCLOLEUCINE; ELECTROSHOCK; EXCITATORY AMINO ACID AGONISTS; GLYCINE; HIPPOCAMPUS; IMIPRAMINE; INOSITOL PHOSPHATES; MALE; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; RESORCINOLS;

EID: 0032524219     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00169-1     Document Type: Article

References (24)

1. Abdul Ghani M.A., Valiante T.A., Carlen P.L., Pennefather P.S. Metabotropic glutamate receptors coupled to IP3 production mediate inhibition of IAHP in rat dentate granule neurons. J. Neurophysiol. 76:1996;2691-2700.
2. Bijak M. Antidepressant drugs potentiate the alpha 1-adrenoceptor effect in hippocampal slices. Eur. J. Pharmacol. 166:1989;183-191.
3. Bijak M., Tokarski K., Maj J. Repeated treatment with antidepressant drugs induces subsensitivity to the excitatory effect of 5-HT4 receptor activation in the rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;14-19.
4. Daniel W., Adamus A., Melzacka M., Szymura J., Vetulani J. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Naunyn-Schmiedeberg's Arch. Pharmacol. 317:1981;209-213.
5. Davies C.H., Clarke V.R.J., Jane D.E., Collingridge G.L. Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones. Br. J. Pharmacol. 116:1995;1859-1869.
6. Henry P., Pearson W.L., Nichols C.G. Protein kinase C inhibition of cloned inward rectifier (HRK1/KIR2.3) K+ channels expressed in Xenopus oocytes. J. Physiol. (London). 495:1996;681-688.
7. Janowsky D.S., el Yousef M.K., Davis J.M., Sekerke H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. ii:1972;632-635.
8. 3H] Inositol Phospholipid Turnover. In: Yamamura, H.I., Enna, S.J., Kuhar, M.J. (Eds.), Methods in Neurotransmitter Receptor Analysis. Raven Press, New York, pp. 69-87.
9. Lapin T.P., Oxenkrug K.F. Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet. 1:1969;132-136.
10. Layer R.T., Popik P., Olds T., Skolnick P. Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol. Biochem. Behav. 52:1995;621-627.
11. Lesch K.P., Aulakh C.S., Wolozin B.L., Murphy D.L. Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression. Pharmacol Toxicol. 71:1992;49-60. Suppl. 1.
12. Lloyd K.G., Thuret F., Pilc A. Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J. Pharmacol. Exp. Ther. 235:1985;191-199.
13. Mann C.D., Vu T.B., Hrdina P.D. Protein kinase C in rat brain cortex and hippocampus: Effect of repeated administration of fluoxetine and desipramine. Br. J. Pharmacol. 115:1995;595-600.
14. Mc Geer, P.L., Eccles, J.C., Mc Geer, E.G., 1987. In: Mc Geer, P.L., Eccles, J.C., Mc Geer, E.G. (Eds.), Molecular Neurobiology of the Mammalian Brain. Plenum, New York.
15. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29:1989;365-402.
16. Peretz T., Levin G., Moran O., Thornhill W.B., Chikvashvili D., Lotan I. Modulation by protein kinase C activation of rat brain delayed-rectifier K+ channel expressed in Xenopus oocytes. FEBS Lett. 381:1996;71-76.
17. Pilc A., Legutko B. Antidepressant treatment influences cyclic AMP accumulation induced by excitatory amino acids in rat brain. Pol. J. Pharmacol. 47:1995;359-361.
18. Pilc A., Legutko B. The influence of prolonged antidepressant treatment on the changes in cyclic AMP accumulation induced by excitatory amino acids in rat cerebral cortical slices. NeuroReport. 7:1995;85-88.
19. Pin J.P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
20. Saugstad J.A., Segerson T.P., Westbrook G.L. Metabotropic glutamate receptors activate G-protein-coupled inwardly rectifying potassium channels in Xenopus oocytes. J. Neurosci. 16:1996;5979-5985.
21. Schildkraut J.J. The catecholamine hypothesis of affective disorder: a review of supporting evidence. Am. J. Psychiatry. 122:1965;1032-1039.
22. Schoepp D.D., Goldsworthy J., Johnson B.G., Salhoff C.R., Baker S.R. 3,5-dihydroxyphenylglycines is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. J. Neurochem. 63:1994;769-772.
23. Sharon D., Vorobiov D., Dascal N. Positive and negative coupling of the metabotropic glutamate receptors to a G protein-activated K+ channel GIRK, in Xenopus oocytes. J. Gen. Physiol. 109:1997;477-490.
24. Skolnick P., Layer R.T., Popik P., Nowak G., Paul I.A., Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry. 29:1996;23-26.